is there an age limit for glp 1 What Older Adults Should Know About GLP-1 Drugs as Medicare Coverage Expands GLP-1 Weight-Loss Drug Demonstration Begins

Sanofi Industry Developments July 2026: Novo Nordisk received CDSCO approval for Wegovy (semaglutide) as the first and only GLP-1 receptor agonist approved in India for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, expanding the drug's indication beyond weight management and type 2 diabetes

Confirm whether any current medications, health conditions, pregnancy status, or family medical history may affect your eligibility - ask your assigned provider during intake

S.LeitoC

For most patients with vitamin B12 deficiency, high-dose oral supplements are as effective as intramuscular injections at raising serum B12 levels and resolving symptoms